{"name":"Acanthas Pharma Inc","slug":"acanthas-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQdnFnYWY2RldDblVidnduaGJTMnQ0Mm5NZGRaTC1kbGV3WHhPay1hYV8zTi1pLWJpdHFNc2dMVldDenBBOGhqX29mcjIxcEd4aGd3MERTeVpqWFcxZTlKMmhmcjVkRDdocExDWTdKZUYyZ2I5T0NKWEJBNDctWHpkRWQ5TDBFXzF0c3NxNXhrRUR2U3lNanRBNkxOWVRfNFZ2Mzd0RExkVGlXeUtDNmVoUkE2U3BndzFOVU5vdnRQRVhOWDVzVjF6cDZrWVR5VnJYUy1jd0RsYUFUSVZTTVFhS2FRVWNxWG1pTkxwUVhUMVFJSGZWWXZXaXNwNFM0dk41eHFxa3NwaC1sSlVuLWNyVEk1cEQ4dw?oc=5","date":"2025-09-25","type":"trial","source":"PR Newswire","summary":"AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer - PR Newswire","headline":"AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Me","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOVVh2S1A2RG52NUNMZEtWNlFVYXJIZ3ExWjh2WmVJZDl5X0ZCYzB3WTNwXzlMaTdGODFDMExGNHZHU3hzS2U4MkkxNXF6WW96aDZGalB4R3JpOV9HaTJqWjFMWHhBR185clNFWEpXT1ZpaFFVaks0ZnpoYmQ3YmlFbVc5N0FGNGRaeU96QWxqYnpNM2VaSC1kRXI0aVN0T0ZSblh6QkNvME5UcWJlRm9CTzBNRXpiWGNvVm83VGRNQjJJLUlMNl95WFFXRkoyaGxmQzFFbEVLWDJaMzA5aWFWLWllT0dKdnliOWhzeVlTaGtEaVMwZXhZcHYzdUxBME1WVE5xQ0ZZOXYzZy1tUlNLd0F3UzI?oc=5","date":"2025-09-04","type":"trial","source":"PR Newswire","summary":"AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS) - PR Newswire","headline":"AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral scl","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNaVpnTnc3b3FfN1VwVENqMGRHVl9vY3R1SmhRbnFJTWg2NTFEd2ZXTEZpNmdPemVTeFNScks2R3h6QUFfNW82NmRxc1JJclVsS1BSZ0syYUJiQVhqSDRHczdKWk5ZNnZUWm94WFFKOUthc0x1WElFZVplbC1xeDVKWm5B?oc=5","date":"2023-03-01","type":"pipeline","source":"Stony Brook University","summary":"Anti-Cancer Agent Developed at SBU Shows Great Promise Against Tumors - Stony Brook University","headline":"Anti-Cancer Agent Developed at SBU Shows Great Promise Against Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxPb0lfY1RVM0Rjd0RtY1cyYXNoWkwyRVFIMGFCQzkyNnI5MjRiTEdtLWNuV21icURTenl3WGdoYUltQWtwQ01DQjByTm5fOHlIaWlmdkJBMUZ4dEhWWlVzX1p6T2VGdThuSGtYSDRxb1I1eGJHa0RMaTFaaFF1ekQ2RGpCTzZ2eGEyNWU2Qm1BUFFpa3ROZk91RGlLYlZMNW9EeC1RZTV5NmptTk90MFNaS3lXYnQ3cXpEOXlrX3NBNDU5N0l1em1NRzUzX2c4MVlKcnRLU1d5Y1pGQmZYbUNuMmNrbTZHR29Za2VFVXFoUGtkNmxZY0NldXgxS0lUZWNoZDcxZE9hMThpMGV0SWR4Vg?oc=5","date":"2023-02-21","type":"pipeline","source":"GlobeNewswire","summary":"Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ - GlobeNewswire","headline":"Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPUjBaNDB0dkl4eW1rX1U0d3hrdTFlYWFrX0tid3VSeU5OcFVfMWlTOEU2STktNU42em5jZllXbTNZd3llMko4RVFCdW93eUk4b0xqUWJMMnpPUk4yT2NaQmVzWFh6UjB1SU5MM3M4T1pNS0ZLQXFNOW14WmIydWl3b01TMVRPcGpHRkpwNXV4QkgwbnVyUEE3OWdsc3pVZ3c?oc=5","date":"2023-02-09","type":"pipeline","source":"BioWorld News","summary":"TVM invests $25M in new IgE-directed antibody allergy play - BioWorld News","headline":"TVM invests $25M in new IgE-directed antibody allergy play","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}